Table 2.

Relationship Between TFAP2s and Clinicopathologic Characteristics in Patients with Bladder Cancer from FFPE Cohort

Parameter	Chi-squared test Mean difference and P value
	TFAP2A	TFAP2B	TFAP2C	TFAP2D	TFAP2E
Age (<65 vs ≥65) (126 vs 114)	p=0.685	p =0.941	p =0.142	p = 0.924	p =0.225
Gender (Female vs Male) (36 vs 204)	p =0.150	p =0.867	p =0.926	p =0.899	p =0.498
Grade (Low vs High) (20 vs 220)	p =0.473	p =0.308	p =0.919	p =0.477	p =0.669
Molecular subtype (Basal vs Luminal) (92 vs 148)	3.040 p <0.001	p =0.219	2.528 p <0.001	p =0.381	p =0.362
T stage (T1-2 vs T3-4) (164 vs 76)	1.741 p =0.001	1.231 p =0.009	p =0.540	P=0.931	3.003 p <0.001
N stage (N1 vs N0) (148 vs 92)	1.773 p <0.001	p =0.945	1.143 p =0.004	p =0.069	1.220 p =0.019